Company profile for HeartSciences

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

HeartSciences seeks to bridge today’s “diagnostic gap” in cardiac care by providing effective front-line solutions that assist in the detection of heart disease in at-risk patients. HeartSciences has invested years of R&D focused on advancing the field of electrocardiography through the use of technology to develop new algorithms focused on detecting cardiac conditions not previously available in ECG devices. HeartScienc...
HeartSciences seeks to bridge today’s “diagnostic gap” in cardiac care by providing effective front-line solutions that assist in the detection of heart disease in at-risk patients. HeartSciences has invested years of R&D focused on advancing the field of electrocardiography through the use of technology to develop new algorithms focused on detecting cardiac conditions not previously available in ECG devices. HeartSciences’ MyoVista® Wavelet ECG (wavECG™) Cardiac Testing Device uses an advanced form of signal processing called continuous wavelet transform (CWT).

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
550 Reserve Street, Suite 360 Southlake, TX 76092
Telephone
Telephone
1+ 737-414-9213
Linkedin
Linkedin
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

BPI Europe

BPI Europe

Not Confirmed

envelop Contact Supplier

BPI Europe

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.globenewswire.com/news-release/2026/04/14/3273913/0/en/HeartSciences-Reminds-Its-Shareholders-to-Submit-Their-Vote-at-the-Upcoming-April-30-2026-Annual-Shareholders-Meeting.html

GLOBENEWSWIRE
14 Apr 2026

https://www.globenewswire.com/news-release/2026/03/25/3262174/0/en/HeartSciences-MyoVista-Insights-Receives-Epic-Toolbox-Designation-for-ECG-Management-System-Category.html

GLOBENEWSWIRE
25 Mar 2026

https://www.globenewswire.com/news-release/2026/03/24/3261516/0/en/HeartSciences-to-Present-at-Investor-Summit-Group-Virtual-Conference-and-Host-Virtual-One-on-One-Investor-Meetings.html

GLOBENEWSWIRE
24 Mar 2026

https://www.globenewswire.com/news-release/2026/03/16/3256725/0/en/HeartSciences-Reports-Fiscal-Third-Quarter-2026-Financial-Results-and-Provides-Business-Update.html

GLOBENEWSWIRE
16 Mar 2026

https://www.globenewswire.com/news-release/2026/02/05/3232988/0/en/University-of-West-England-Adopts-HeartSciences-MyoVista-Insights-Platform-and-MyoVista-wavECG-Device-to-Establish-ECG-Education-and-Technology-Reference-Center.html

GLOBENEWSWIRE
05 Feb 2026

https://www.globenewswire.com/news-release/2025/12/15/3205858/0/en/HeartSciences-Reports-Fiscal-Second-Quarter-2026-Financial-Results-and-Provides-Business-Update.html

GLOBENEWSWIRE
15 Dec 2025

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty